newsfilter
← Latest News
ACCESS Newswire·

Ensysce Biosciences Advances CRPS Program at Painweek 2026, Contributes to FDA Hearing on Psychedelic Drug Regulation

SAN DIEGO, CA / ACCESS Newswire / September 15, 2026 / Ensysce Biosciences, Inc. a clinical-stage biotechnology company developing novel neuroplastogenic